Between 2002 and January 2011, 202 consecutive patients without prior mitral valve surgery (age 75 ¡À 9 years; 63 % were male) with symptomatic functional (65 % ), degenerative (27 % ), or mixed (8 % ) mitral regurgitation were treated with a percutaneous clip system for approximation of the anterior and posterior mitral leaflets. Risk for mitral valve surgery was considered high in terms of a mean logistic European System for Cardiac Operative Risk Evaluation of 44 % (range, 21 % -54 % ). Preprocedural left ventricular ejection fraction was 35 % or less in 36 % of patients. An interdisciplinary heart team of cardiologists and cardiac surgeons discussed all patients.
Percutaneous clip implantation was successful in 186 patients (92 % ). Patients were treated with 1 clip (n?=?125; 62 % ), 2 clips (n?=?64; 32 % ), or 3 or more clips (n?=?7; 3 % ). Reduction in mitral regurgitation from pre- to postprocedure was significant (P?<?.0001) and remained stable within the first 12 months in the majority of patients. Thirty-day mortality was 3.5 % (7/202 patients). Hospital stay was 12 ¡À 10 days, and median intensive care unit stay was 1 day (range, 0-45 days). Eleven patients required surgical valve repair/replacement at a median of 38 days (0-468 days) after percutaneous clip implantation.
Clip-based percutaneous mitral valve repair is a safe, low-risk, and effective therapeutic option in symptomatic patients with a high risk for surgery and does not exclude later surgical repair.